Legal Representation
Attorney
Kristen Ruisi
USPTO Deadlines
Application History
16 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Nov 26, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
Nov 26, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Oct 15, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Oct 15, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Sep 25, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Sep 10, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Sep 10, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Sep 10, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Sep 10, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Aug 28, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Aug 28, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Aug 28, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Aug 27, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jul 13, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jul 13, 2024 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
Feb 22, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals and pharmaceutical preparations, namely, for the treatment of Tourette Syndrome and other central nervous system disorders
Class 042
Research and development of medications and treatment for central nervous system disorders
First Use Anywhere:
Mar 1, 2019
First Use in Commerce:
Mar 1, 2019
Class 044
Providing healthcare and medical information; healthcare services, namely providing information in the field of health, wellness, Tourette Syndrome and other central nervous system disorders; providing website featuring information in the field of central nervous system disorders treatments; providing information, news, and commentary in the field of central nervous system disorders
First Use Anywhere:
Mar 1, 2019
First Use in Commerce:
Mar 1, 2019
Additional Information
Design Mark
The mark consists of the words "EMALEX BIOSCIENCES" with an arrow shaped gap between the top and bottom of the X.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
BIOSCIENCES